Charles River Laboratories International, Inc.
CRL
$155.46
$2.801.83%
NYSE
| 12/27/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.93% | -21.87% | -47.52% | -62.17% | -214.65% |
| Total Depreciation and Amortization | 91.95% | -83.94% | 80.07% | -0.58% | -19.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.72% | 569.99% | -172.86% | 137.51% | 513.02% |
| Change in Net Operating Assets | 115.97% | -107.20% | 198.54% | 102.68% | -210.44% |
| Cash from Operations | -7.43% | -15.08% | 5.72% | 32.19% | -27.87% |
| Capital Expenditure | -17.63% | 8.11% | 10.61% | 25.04% | 3.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -690.37% | -89.17% | 87.92% | 45.91% | 96.84% |
| Cash from Investing | -21.95% | -58.02% | 39.65% | 46.99% | 68.07% |
| Total Debt Issued | 49.50% | -54.37% | 24.23% | 38.37% | -76.36% |
| Total Debt Repaid | -17.56% | 23.01% | -6.25% | 48.92% | 44.89% |
| Issuance of Common Stock | -7.42% | -99.74% | -99.88% | -- | -87.07% |
| Repurchase of Common Stock | 22.58% | 99.91% | 17.52% | -3,676.41% | 10.79% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 70.61% | 53.74% | -21.76% | -766.85% | 5.06% |
| Cash from Financing | 31.65% | 26.46% | 20.62% | -674.10% | -161.41% |
| Foreign Exchange rate Adjustments | 129.21% | -139.38% | 479.08% | 162.78% | -205.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 211.65% | -20.09% | 70.17% | -51.61% | -105.11% |